Reported results
- Net sales increased 2.1% to $10.4 billion (GAAP).
- Net income increased 42.5% to $218 million (GAAP).
- Diluted EPS increased 49.3% to $1.00 (GAAP).
- Adjusted EBITDA increased 9.9% to $555 million (non-GAAP).
- Adjusted Diluted EPS increased 17.8% to $1.26 (non-GAAP).
- Adjusted EBITDA margin increased 38 basis points to 5.3% (non-GAAP).
Guidance
- Net Sales growth of 4% to 5%
- Adjusted EBITDA growth of 9% to 11%
- Adjusted Diluted EPS growth of 18% to 20%
Notes
The guidance provided includes the impact of a 53rd week in fiscal year 2026, which is expected to add approximately 1% to total case growth and Adjusted EBITDA growth.
Price and volatility reaction
The stock moved -2.8% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -8.1 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 109.93 | 2026-11-04 |
| Close after release | 106.85 | 2026-11-05 |
| Realised move | -2.8% | close to close |
| 30d ATM IV change | -8.1 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.
